Validating New Tuberculosis Computational Models with Public Whole Cell Screening Aerobic Activity Datasets
暂无分享,去创建一个
[1] Gautam R. Desiraju,et al. A Virtual Screening Approach for Thymidine Monophosphate Kinase Inhibitors as Antitubercular Agents Based on Docking and Pharmacophore Models. , 2005 .
[2] Ying Zhang,et al. The magic bullets and tuberculosis drug targets. , 2005, Annual review of pharmacology and toxicology.
[3] A. Ghose,et al. Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods , 1998 .
[4] Antony J. Williams,et al. Free online resources enabling crowd-sourced drug discovery , 2009 .
[5] Joel S. Freundlich,et al. Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. , 2011, Trends in Microbiology.
[6] Sean Ekins,et al. Computational Approaches That Predict Metabolic Intermediate Complex Formation with CYP3A4 (+b5) , 2007, Drug Metabolism and Disposition.
[7] Lynn Rasmussen,et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. , 2009, Tuberculosis.
[8] Sean Ekins,et al. When pharmaceutical companies publish large datasets: an abundance of riches or fool's gold? , 2010, Drug discovery today.
[9] Sean Ekins,et al. Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs , 2010 .
[10] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. , 2001, Advanced drug delivery reviews.
[11] R. Reynolds,et al. High Throughput Screening for Inhibitors of Mycobacterium tuberculosis H 37 Rv , 2012 .
[12] Lynn Rasmussen,et al. Antituberculosis activity of the molecular libraries screening center network library. , 2009, Tuberculosis.
[13] Gisbert Schneider,et al. Virtual screening: an endless staircase? , 2010, Nature Reviews Drug Discovery.
[14] Robert A. Field,et al. New Small-Molecule Synthetic Antimycobacterials , 2005, Antimicrobial Agents and Chemotherapy.
[15] Brian Hudson,et al. Strategic Pooling of Compounds for High-Throughput Screening , 1999, J. Chem. Inf. Comput. Sci..
[16] Jean M. Severin,et al. Toxicological evaluation of thiol-reactive compounds identified using a la assay to detect reactive molecules by nuclear magnetic resonance. , 2007, Chemical research in toxicology.
[17] Sean Ekins,et al. A collaborative database and computational models for tuberculosis drug discovery. , 2010, Molecular bioSystems.
[18] James F Blake,et al. Identification and evaluation of molecular properties related to preclinical optimization and clinical fate. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).
[19] Sean Ekins,et al. Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibition. , 2010, Chemical research in toxicology.
[20] Sean Ekins,et al. Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis. , 2010, Molecular bioSystems.
[21] Pedro M Alzari,et al. Rising standards for tuberculosis drug development. , 2008, Trends in pharmacological sciences.
[22] Sarah R. Langdon,et al. Predicting cytotoxicity from heterogeneous data sources with Bayesian learning , 2010, J. Cheminformatics.
[23] Jeffrey R. Huth,et al. Enhancement of chemical rules for predicting compound reactivity towards protein thiol groups , 2007, J. Comput. Aided Mol. Des..
[24] Philip Prathipati,et al. Global Bayesian Models for the Prioritization of Antitubercular Agents , 2008, J. Chem. Inf. Model..
[25] Renaldo Mendoza,et al. ALARM NMR: a rapid and robust experimental method to detect reactive false positives in biochemical screens. , 2005, Journal of the American Chemical Society.
[26] R. Buxton,et al. New anti-tuberculosis agents amongst known drugs. , 2009, Tuberculosis.
[27] M. Matsumoto,et al. OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice , 2006, PLoS medicine.
[28] Thomas R Ioerger,et al. Discovery of novel nitrobenzothiazole inhibitors for Mycobacterium tuberculosis ATP phosphoribosyl transferase (HisG) through virtual screening. , 2008, Journal of medicinal chemistry.
[29] Sean Ekins,et al. Essential Metabolites of Mycobacterium tuberculosis and Their Mimics , 2011, mBio.
[30] Tudor I. Oprea,et al. Is There a Difference Between Leads and Drugs? A Historical Perspective. , 2001 .
[31] Clifton E. Barry,et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.
[32] Ajay,et al. Recognizing molecules with drug-like properties. , 1999, Current opinion in chemical biology.